Enzalutamid Sandoz eco 40 mg
Enzalutamid Sandoz eco 40 mg is a medicine authorised by Swissmedic under authorisation number 69988. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 July 2025 and the authorisation is limited until 13 July 2030. ATC code L02BB04 places the medicine in the group Endocrine therapy.
| Authorisation number | 69988 |
|---|---|
| Name | Enzalutamid Sandoz eco 40 mg |
| Full name | Enzalutamid Sandoz eco 40 mg, Filmtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BB04 |
| First authorisation | 14 July 2025 |
| Authorisation validity | 13 July 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Enzalutamid Sandoz eco 40 mg, Filmtabletten | B | 14 July 2025 |
| 2 | Enzalutamid Sandoz eco 80 mg, Filmtabletten | B | 14 July 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 112 | Tablette(n) | L02BB04 | 07.16.2. | B |
| 2 | 56 | Tablette(n) | L02BB04 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Enzalutamid Sandoz eco 40 mg authorised in Switzerland?
Yes. Enzalutamid Sandoz eco 40 mg is authorised by Swissmedic under authorisation number 69988, data as of 01 September 2026. The authorisation is limited until 13 July 2030.
Which dispensing category does Enzalutamid Sandoz eco 40 mg have?
Enzalutamid Sandoz eco 40 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Enzalutamid Sandoz eco 40 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.